Bio-Rad (BIO) Stock Price & AI Analysis

NYSE
USA

$353.86

$11.44
(3.34%)

Subscribe to get
AI Score

Bio-Rad Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Bio-Rad | Latest news

Tennis star announces divorce in bizarre video with husband eating banana

TENNIS star Arina Rodionova announced she has is getting divorced in a bizarre video after setting...

The US Sun - 9 hours ago

TV meteorologist Sam Kuffel fired by CBS affiliate after blasting Elon Musk’s...

By that afternoon, her name and bio had been removed from the channel’s website. The Independent has...

The Independent US - 54 minutes ago

Hollyoaks’ Davinia Taylor’s ‘bio-hacking’ wellness routine, from nootropics to...

Davinia Taylor is a big advocate of bio-hacking, which is the practice of 'hacking' your biology to...

Yahoo Life UK - 8 hours ago

We Think Zura Bio (NASDAQ:ZURA) Can Afford To Drive Business Growth

Having said that, unprofitable companies are risky because they could potentially burn through all...

Simply Wall St - 1 day ago

MacKay Bridge reopens, evacuation order lifted after chemical scare

A mandatory evacuation order issued for the area around the Bedford Institute of Oceanography (BIO)...

CBC - 24 hours ago

Cantor Fitzgerald Forecasts Tourmaline Bio FY2025 Earnings

Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Tourmaline Bio in a report released on ...

ETF DAILY NEWS - 18 hours ago

Climb Bio (NASDAQ:CLYM) Shares Down 0.5% – What’s Next?

Climb Bio, Inc. (NASDAQ:CLYM – Get Free Report) traded down 0.5% during trading on Wednesday . The company traded as low as $1.78 and last traded at $1.87. 260,564 shares changed hands during ...

ETF DAILY NEWS - 17 hours ago

FACT CHECK: Social Media Post In Which Greenland Premier Appears To Troll Trump...

A post shared on X claims Greenland Premier Mute B. Egede purportedly said, “If Trump can’t handle...

CheckYourFact - 1 hour ago

Tevogen Bio Holdings Inc. (TVGN): AI Innovations in Immunotherapy

We recently published a list of Complete List of All AI Companies Under $2 Billion Market Cap. In...

Insider Monkey - 6 days ago

Brokerages Set Zura Bio Limited (NASDAQ:ZURA) PT at $15.80

Zura Bio Limited (NASDAQ:ZURA – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that are presently covering the firm, MarketBeat Ratings reports. One analyst ...

ETF DAILY NEWS - 2 days ago